triazoles has been researched along with Meningitis, Cryptococcal in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (12.50) | 18.2507 |
2000's | 13 (40.63) | 29.6817 |
2010's | 14 (43.75) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Cheng, L; Dai, Q; Feng, W; Sun, F; Xia, P; Yang, B; Yang, M; Yu, M; Yuan, Q | 1 |
Bartuska, A; de Castro, GC; Franke, KS; Giamberardino, C; Hope, WW; Kovanda, LL; McEntee, L; Perfect, JR; Ripple, K; Smilnak, G; Toffaletti, DL | 1 |
Capilla, J; Flavia, A; Guarro, J; Mayayo, E | 1 |
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
Bocanegra, R; Kirkpatrick, WR; Kovanda, L; Najvar, LK; Olivo, M; Patterson, TF; Wiederhold, NP | 1 |
Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M | 1 |
dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
Bandettini, R; Calvillo, M; Castagnola, E; Conte, M; Cuzzubbo, D; Faraci, M; Lanino, E; Manzitti, C; Miano, M; Micalizzi, C; Morreale, G; Pescetto, L; Ravegnani, M; Ricagni, L; Soro, O | 1 |
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH | 1 |
Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
Hogan, BK; Lewis, JS; Nierenberg, NE; Patterson, TF; Thompson, GR | 1 |
Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y | 1 |
Yong, L | 1 |
Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E | 1 |
Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
Flores, VG; Martinez, EA; Tovar, RM; Zaldivar, PG | 1 |
Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D | 1 |
Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A | 1 |
Bartroli, J; Benjamin, DK; Boyce, M; Miller, JL; Perfect, JR; Schell, WA; Toffaletti, DL; Wills, EA | 1 |
Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S | 1 |
Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
Lu, HZ; Shen, YZ; Wang, JR | 1 |
Graybill, JR; Lewis, JS | 1 |
Cox, GM; Dodge, RK; Perfect, JR; Schell, WA | 1 |
Barchiesi, F; Graybill, JR; Luther, MF; Najvar, LK; Restrepo, MI | 1 |
Barchiesi, F; Bocanegra, R; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Giacometti, A; Giannini, D; Graybill, JR; Najvar, LK; Scalise, G; Schimizzi, AM | 1 |
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
Chambers, HF; Lee, BL; Padula, AM; Sande, MA; Täuber, MG | 1 |
Allendoerfer, R; Graybill, JR; Loebenberg, D; Marquis, AJ; Rinaldi, MG; Yates, RR | 1 |
Albert, MM; Graybill, JR; Rinaldi, MG | 1 |
1 review(s) available for triazoles and Meningitis, Cryptococcal
Article | Year |
---|---|
Fungicidal versus Fungistatic: what's in a word?
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Cryptococcus; Echinocandins; Humans; Meningitis, Cryptococcal; Microbiological Techniques; Polyenes; Triazoles | 2008 |
31 other study(ies) available for triazoles and Meningitis, Cryptococcal
Article | Year |
---|---|
A Novel Cryptococcal Meningitis Therapy: The Combination of Amphotericin B and Posaconazole Promotes the Distribution of Amphotericin B in the Brain Tissue.
Topics: Amphotericin B; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain; Cryptococcus neoformans; Dibenzocycloheptenes; Diketopiperazines; Disease Models, Animal; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Meningitis, Cryptococcal; Mice; Molecular Docking Simulation; Quinolines; Serum Albumin; Tissue Distribution; Triazoles | 2020 |
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.
Topics: Animals; Antifungal Agents; Area Under Curve; Brain; Cryptococcus neoformans; Disease Models, Animal; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Models, Theoretical; Nitriles; Pyridines; Rabbits; Triazoles | 2019 |
Efficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine model.
Topics: Amphotericin B; Animals; Cryptococcus neoformans; Drug Resistance, Bacterial; Drug Therapy, Combination; Male; Meningitis, Cryptococcal; Mice; Survival; Treatment Outcome; Triazoles | 2013 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.
Topics: Animals; Antifungal Agents; Brain; Cryptococcus neoformans; Disease Models, Animal; Meningitis, Cryptococcal; Mice; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2016 |
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2008 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Male; Meningitis, Cryptococcal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2010 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
Topics: Anti-HIV Agents; Antifungal Agents; Cerebrospinal Fluid; Dideoxynucleosides; Drug Monitoring; HIV Infections; Humans; Interferon-gamma; Lamivudine; Male; Meningitis, Cryptococcal; Pyrimidines; Ritonavir; Serum; Triazoles; Voriconazole; Young Adult | 2010 |
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole: may be an option for treatment of cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Humans; Infant, Newborn; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2011 |
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
Meningitis due to Cryptococcus neoformans: treatment with posaconazole.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Humans; Male; Meningitis, Cryptococcal; Mexico; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2012 |
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2012 |
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Quinazolines; Rabbits; Survival Analysis; Triazoles | 2004 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2004 |
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole in an infant with cryptococcal meningitis.
Topics: Antifungal Agents; Humans; Infant; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Rabbits; Triazoles | 1996 |
Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Mice; Microbial Sensitivity Tests; Morpholines; Survival Rate; Triazoles | 2000 |
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antifungal Agents; Follow-Up Studies; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Triazoles; Zidovudine | 1992 |
Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.
Topics: Administration, Oral; Animals; Antifungal Agents; Azoles; Coccidioides; Coccidioidomycosis; Cryptococcus neoformans; Culture Techniques; Isomerism; Meningitis, Cryptococcal; Mice; Triazoles | 1992 |
Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.
Topics: Amphotericin B; Animals; Body Burden; Brain; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Meningitis, Cryptococcal; Mice; Mice, Inbred BALB C; Neisseria meningitidis; Triazoles | 1991 |